Business
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against First Choice Healthcare Solutions, Inc.
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against First Choice Healthcare Solutions, Inc..
About this update from First Choice Healthcare Solutions, Inc.
[{"type":"text","content":"\nLOS ANGELES, May 28, 2019 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 28, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of First Choice Healthcare Solutions, Inc. (“First Choice” or the “Company”) (OTC: FCHS) investors who: (a) acquired securities between April 1, 2014 and November 14, 2018, inclusive (the “Class Period”). First Choice investors have until May 28, 2019 to file a lead plaintiff motion.\n If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to [email protected], or visit our website at www.glancylaw.com. On November 14, 2018, both a criminal indictment and civil action were filed by the U.S. Department of Justice and Securities and Exchange Commission respectively against then-Chief Executive Officer, President, and Board Chairman Christian Romandetti, Sr., along with other alleged co-conspirators. Romandetti was charged regarding his connections with the arrangement of a multi-million dollar pump-and-dump scheme in which the price and volume of First Choice shares was falsely controlled through artificial generation of trading volume and price movements, as well as materially false representations and omissions in communications with investors. On this news, shares of First Choice fell $0.66 per share, or over 65%, to close at $0.35 on November 15, 2018, thereby injuring investors. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) defendants retained Elite Stock Research, Inc. to falsely promote the Company to materially inflate the price of First Choice stock; (2) the Company’s CEO participated and personally profited from a scheme to materially inflate the price ...